chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a licensed practical nurse concerning 11 week patient who on 16-MAR-2007 (twelve days ago) was vaccinated with the first dose of Rotateq (Lot # 656191/1365F). On 28-MAR-2007 the patient experienced inadvertently vaccinated with second dose of Rotateq (Lot # 656191/1365F).
Bad Headache that began Monday afternoon (currently comes in waves) Hives/ Red Rashes all over body started Monday night (currently present)  Shortness of Breath began Monday afternoon over by Monday Night
Leg pain, hips and waist later moved into shoulders and arms Dr. visit June 2021 PMR returned and diagnosed July 2021
Patient also states that was sick after receiving the first dose; Potential Adverse Event : Deviation of time between the two doses; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Patient also states that was sick after receiving the first dose) and INTENTIONAL PRODUCT USE ISSUE (Potential Adverse Event : Deviation of time between the two doses) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Patient also states that was sick after receiving the first dose) and INTENTIONAL PRODUCT USE ISSUE (Potential Adverse Event : Deviation of time between the two doses). At the time of the report, ILLNESS (Patient also states that was sick after receiving the first dose) and INTENTIONAL PRODUCT USE ISSUE (Potential Adverse Event : Deviation of time between the two doses) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Patient has rash and dark line surrounding rash. Patient complained of itching but no bruising or difficulty breathing.  Instructed patient to keep an eye on it and let her doctor and us know if it does not clear up. told her to try some benadryl at bedtime to see if helps clear it up. Told her to go to ER immediately if have difficulty breathing, swelling or bruising.
Got one vaccine earlier this year and still got the flu; Initial information regarding an unsolicited valid non-serious case was received from a consumer (patient) via social media and transmitted to Sanofi on 17-Nov-2020.  This case involved patient with an unknown age who got one dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer lot number unknown via an unknown route in an unknown administration site for prophylactic vaccination) earlier this year and still got the flu (influenza)  The patient's medical history, medical treatments, vaccinations, concomitant medications and family history were not provided.   No relevant laboratory tests were reported.  It was not reported if the patient received a corrective treatment.  Event outcome was reported as Unknown for influenza.  There will be no information regarding the batch number for the case.
First dose of vaccination given 4/21/21 lot: EW0172 (pfizer), second dose given 5/7/21 (pfizer) lot #EW0183 5 days earlier than anticipated vax accidentally gave him the vaccine without confirming with clinical ops. Doctor was aware of the situation and said he can let him go if no reaction. No reaction occured.
Patient reports tenderness and soreness at injection site. It started the day vaccine was administered and has persisted. He stated the pain is not severe and he is able to move his arm and lift objects, but it feels sore and tender when touched. He was advised to contact his Dr. if pain persists or worsens.
Patient reports flu-like symptoms, burning eyes, and weakness starting about 2 hours after the vaccine.  They have continued up to the time of submission of this form (9/15/2021 1:30PM)
77-year-old female with prior non-Hodgkin's lymphoma (dx 2003 s/p chemotherapy, no recurrence), T2DM, HTN, and hypothyroidism who presented to the ER on 4/17/21 with progressive shortness of breath, diarrhea, and constitutional symptoms of fatigue, nausea, vomiting and diarrhea.  Pt reports his symptoms started pretty much of the same day of his vaccine.  Patient states that he had like 8 episodes of diarrhea the day of and the day.after second Covid vaccine on 4/15/21  found to have respiratory failure requiring BiPAP with severe sepsis admitted to the ICU.  Imaging showed dense consolidation of left lung and respiratory symptomatology consistent with pneumonia.  Started on IV Zosyn with significant improvement.  He did have sepsis based fluid resuscitation and was mildly fluid overloaded, though improved with gentle diuresis, no further required.  Ultimately found to have strep pneumoniae bacteremia.  Transitioned to oral Augmentin to complete 14-day course and discharged on 4/20/21. He was readmitted on 8/26/21 with the sudden onset of sob again and found to be in acute pulmonary edema and admitted again. treated with iv Lasix and antibiotics. the cause for the pulm edema was unclear. his oxygen was weaned and he was sent home on prn Lasix. he has no history of chf and has a normal echocardiogram. he denies changes in medications or diet and follows a low sodium diet his bp is well controlled.
Approximately 6-12 hours post vaccination, patient developed fevers, chills, myalgias. On the day after vaccination, her fevers were as high as 105F. She was acutely ill and was not able to go to work. She was seen in clinic 2 days after the vaccination, she was still febrile to 101.7F, with associated chills, myalgias, dizziness, headache. Improves with tylenol/advil.
pt had large red area-warm to the touch; seen by MD same day; given percocet for pain; oozing form that site; poss allergic; some weeping but warmth & inflammation had subsided;
Initial stomach discomfort beginning minutes after injection. 2-3 days of digestive issues most severely blood in stool that cleared up after a few days. Beginning around 4/3/21 began to have a sore between two toes along with redness and swelling and other redness in hands/wrists and around one eye. Doctor prescribed Antibiotic and antihistamine via tele-med video visit.
Patient came to store 10/29/10 -he stated he had pain after immunization that night & by next day it was "excruciating" and "above a 10" on scale of 1-10. He stated he had no local site redness or warmth. He was seen by his primary care MD the following day. The doctor performed xrays & exam with no result. Patient also went to chiro. Dr. who is having pt use immoblizer.
a secondary respiratory infection; Seasonal Allergies; tested positive for covid 14Jan2022; tested positive for covid 14Jan2022; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 28 year-old male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Allergies: Mountain Cedar is the current allergen" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 14Jan2022, outcome "unknown" and all described as "tested positive for covid 14Jan2022"; RESPIRATORY TRACT INFECTION (medically significant), outcome "unknown", described as "a secondary respiratory infection"; SEASONAL ALLERGY (medically significant), outcome "unknown", described as "Seasonal Allergies". The patient underwent the following laboratory tests and procedures: investigation: (26Dec2021) negative; sars-cov-2 test: (26Dec2021) negative; (14Jan2022) positive. Therapeutic measures were taken as a result of respiratory tract infection, seasonal allergy. Clinical course: Seasonal Allergies. Was being treated for a secondary respiratory infection with Cefdinir after having tested negative for COVID-19, flu and strep around 26Dec. At that point he was given a steroid shot and antihistamine and decongestants. Mountain Cedar is the current allergen in the (withheld) still very high pollen counts reported daily.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Severe pain radiating down arm. Unable to lift arm above shoulder. Treated with Aleve. Unable to sleep, pain level of 10. Pain lessened as days went on but pain level is still intense on 9/25/2011 Ten days after vaccine.
Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Allergic: Itch Generalized-Mild, Additional Details: patient came by pharmacy and I informed her to take benadryl and then call the rph if better or just to let us know how she is.  I followed up with her on 10/19/2022 and left a voicemail asking if she was doing ok and if the benadryl helped.
shortness of breath; runny nose; red at injection site; swelling at injection site; nauseated; chills; Fever of 104 F; bad headache; Body aches; sore arm at injection site; real tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm at injection site), FATIGUE (real tired), VACCINATION SITE ERYTHEMA (red at injection site), VACCINATION SITE SWELLING (swelling at injection site) and NAUSEA (nauseated) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's medical history was not reported.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO), BUPROPION HYDROCHLORIDE (WELLBUTRIN) and HYDROXYCHLOROQUINE for an unknown indication.    On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm at injection site) and FATIGUE (real tired). On 17-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red at injection site), VACCINATION SITE SWELLING (swelling at injection site), NAUSEA (nauseated), CHILLS (chills), PYREXIA (Fever of 104 F), HEADACHE (bad headache), DYSPNOEA (shortness of breath), RHINORRHOEA (runny nose) and MYALGIA (Body aches). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) on 17-Feb-2021 for Adverse event, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PAIN (sore arm at injection site), FATIGUE (real tired), VACCINATION SITE ERYTHEMA (red at injection site), VACCINATION SITE SWELLING (swelling at injection site), NAUSEA (nauseated), CHILLS (chills), PYREXIA (Fever of 104 F), HEADACHE (bad headache), DYSPNOEA (shortness of breath), RHINORRHOEA (runny nose) and MYALGIA (Body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Body temperature: 104 (High) 104 F. On 18-Feb-2021, Body temperature: 100 (High) 100F.
Patient was given MENACTRA vaccine and GARDISIL 9 vaccine in opposite arms. Approximately 2 minutes later patient had syncopal episode from apparent orthostatic hypotension. No evidence of seizure. Patient reports feeling lightheadness prior to syncope. Lost consciousness for 5 seconds. Upon awakening reports dizziness and ear pressure. Patient was diaphoretic and pale. Improved with ice packs, water, and ENSURE after 15-20 minutes.
tested positive for COVID; tested positive for COVID; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at dose 2, single and via an unspecified route of administration on an unspecified date at dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient was tested positive for covid in Jul2021. The patient underwent lab tests and procedures which included sars-cov-2 test: positive in Jul2021. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
it is like it is working on my nerves; my head starts hurting; my eyes itch; my eyelids itch; I have arms crawling symptoms/I have legs crawling symptoms; itching everywhere; my mouth gets really dry; it messes with my speech; it feels like you are hot/it feels like your skin is hot; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUS SYSTEM DISORDER (it is like it is working on my nerves), HEADACHE (my head starts hurting), EYE PRURITUS (my eyes itch), EYELIDS PRURITUS (my eyelids itch) and FORMICATION (I have arms crawling symptoms/I have legs crawling symptoms) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stroke (Eleven years ago patient had a stroke, and she can't use her right arm). Concomitant products included BUPROPION, LEVETIRACETAM, WARFARIN and SIMVASTATIN for an unknown indication.    On 30-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NERVOUS SYSTEM DISORDER (it is like it is working on my nerves), HEADACHE (my head starts hurting), EYE PRURITUS (my eyes itch), EYELIDS PRURITUS (my eyelids itch), FORMICATION (I have arms crawling symptoms/I have legs crawling symptoms), PRURITUS (itching everywhere), DRY MOUTH (my mouth gets really dry), SPEECH DISORDER (it messes with my speech) and FEELING HOT (it feels like you are hot/it feels like your skin is hot). At the time of the report, NERVOUS SYSTEM DISORDER (it is like it is working on my nerves), HEADACHE (my head starts hurting), EYE PRURITUS (my eyes itch), EYELIDS PRURITUS (my eyelids itch), FORMICATION (I have arms crawling symptoms/I have legs crawling symptoms), PRURITUS (itching everywhere), DRY MOUTH (my mouth gets really dry), SPEECH DISORDER (it messes with my speech) and FEELING HOT (it feels like you are hot/it feels like your skin is hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient got the first shot on 30Aug2021. For a while patient did fine. The next week on the 07Sep2021, patient took her medicine, Bupropion and levetiracetam in the morning. Thirty minutes to an hour, patient felt like "it was working on her nerves". It only happens when patient takes this medicine, and patient has taken them for 11 years and it never happened before.   Patient is scheduled for second dose on 27Sep2021.  No treatment medication was mentioned.
Day after Dose 2 vaccination, high temperature radiated pain in shoulder blade the went into chest, nausea and diarrhea. 03/25/2021 teeth chattered and extreme chills and all joints was achy, burning skin sensation, 10am intense midday all symptoms present was present to at bed time of 10:30pm. Next day. Recovered from the signs and symptoms on 03/26/2021. Then in end of April 2021 shortness of breath, pain in chest, radiated pain in shoulder blade that went into chest, center of chest started having pain. I went to a doctor visit 08/18/2021, Internal Medicine Dr. was sent down stairs for chest x ray and EKG. EKG, stress test was abdominal, but chest x-ray was normal. 09/29/2021 was scheduled for a regular stress, was abnormal so I was scheduled for a nuclear stress test on 10/06/2021. The EKG walking treadmill was not normal. Resting EKG was normal for that day. Treadmill was abnormal for the exercise portion abnormal. The pictures was normal. Directives of new blood pressure for high blood new diagnosis , pressure new medication Propranolol 60mg once a day at bedtime. New diagnosis for Cholesterol, Atorvastatin 03/21/2021 Dr. visit 40mg once a night before bed, this an increase from original dose of Atorvastatin 20mg 10/2021. May or June of 2021. Delayed, having a lot of chest pain and heart palpitation. Gastrointestinal, oxygen issue with getting a complete breath, tiredness in chest and pain in bed. Resting abdominal for EKG, stress test was abdominal. Every now and then I chest pains and shortness of breath.
Patient didn't report any symptoms, spoke to pt for a follow up, pt said she saw the doctor and she is fine, she didn't have any questions to pharmacist.
Fatigue; Body aches; Flu like symptoms; This is a spontaneous report from a contactable consumer. A 73-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 22Apr2021 (at the age of 73-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on an unknown date in Apr2021 (at the age of 73-years-old), as a single dose for COVID-19 immunisation. On 24Apr2021, the patient experienced fatigue, body aches, flu like symptoms after second dose lasting two days and unknown if fever occurred. By second day, symptoms were resolving but not completely resolved. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as the result of the events.  Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigue, body aches and flu like symptoms were resolving at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Small cough; Fever of 102 and 103; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Small cough), PYREXIA (Fever of 102 and 103) and FATIGUE (Fatigue) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 007B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced COUGH (Small cough), PYREXIA (Fever of 102 and 103) and FATIGUE (Fatigue). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, COUGH (Small cough), PYREXIA (Fever of 102 and 103) and FATIGUE (Fatigue) had not resolved.            No concomitant product use was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: TCR-Follow up received on 28-May-2021 and contains email address.
Experienced severe mouth ulcers weeks after injection leading to multiple tests, biopsies, etc.  Diagnosed with Pemphigus Vulgaris several months ago, still undergoing treatment.  Severe case of blisters on body and worse in mouth.
chills, body aches, nasal congestion, fever 101.5, dizziness and injection site pain within 6 hours of receiving vaccine.
Shortness of breath, sinus pain/pressure, myalgias, nausea, diarrhea, and productive cough since 12/29/21. Saw her PCP who found her to be tachycardic and hypoxemic and recommended that she come to the ED for further treatment. In the ED, she was tachycardic, tachypneic, febrile, somewhat hypoxic.
About 4 weeks after my J&J vaccine I noticed blurred vision along with (what I can best describe as) ?neon colored eye floaters?; followed by an intense headache that lead to violent vomiting; after that day stopped; but headache, muscle ache (at base of skull and neck /shoulder area), mental fog / inability to focus, mild to intense vertigo all continue to today. A week after chest pain started occurring.
This  76 year old female received the Pfizer Covid shot on 2/15/21    and went to the ED on 4/6 /21     and was admitted  on 4/6/21 with the following diagnoses listed below. D69.6 - Thrombocytopenia, unspecified GI Bleed
jitterness; headache; nausea; slept all day and night; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), HYPERSOMNIA (slept all day and night), NERVOUSNESS (jitterness), HEADACHE (headache) and NAUSEA (nausea) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD.   On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 21-Apr-2021, the patient experienced HYPERSOMNIA (slept all day and night), HEADACHE (headache) and NAUSEA (nausea). On 22-Apr-2021, the patient experienced NERVOUSNESS (jitterness). At the time of the report, PAIN IN EXTREMITY (Sore arm), HYPERSOMNIA (slept all day and night), NERVOUSNESS (jitterness), HEADACHE (headache) and NAUSEA (nausea) outcome was unknown.            For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable. Treatment medication was not provided. concomitant product was not provided   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Follow-up information received on 02-JUN-2021 contains non-significant information.
Reportedly the pt,  immediately, experienced a metallic taste in her mouth which lasted about 1 1/2 hours and then resolved. The pt stated this happened 6 months ago after an injection of Toradol. Reportedly, the pt recovered from this experience. From additional information received on 12/15/98, it was reported, "Reviewed, no additional information at this time, 12/11/1998".
Arm muscle weakness; Difficulty raising the left arm; Redness at injection site; Soreness at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th October 2019, the patient received the 2nd dose of Shingrix (intramuscular). In October 2019, less than a week after receiving Shingrix, the patient experienced injection site erythema and injection site pain. On 21st October 2019, the patient experienced muscle weakness upper limb and injected limb mobility decreased. The patient was treated with ibuprofen. On an unknown date, the outcome of the injection site erythema and injection site pain were recovered/resolved and the outcome of the muscle weakness upper limb and injected limb mobility decreased were unknown.   It was unknown if the reporter considered the injection site erythema, injection site pain, muscle weakness upper limb and injected limb mobility decreased to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the left arm. After vaccination, the patient had usual soreness and redness at the injection site and that has cleared up. 3 days after vaccination, the patient had arm muscle weakness in that had difficulty raising the left arm. The reporter did not consent to follow up. The reporter decline to provide full demographics details and further follow up.